Patents by Inventor Fumiko Ogino

Fumiko Ogino has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8097635
    Abstract: An object of the present invention is to provide a safe and highly effective insulin resistance improving agent or therapeutic agent for type II diabetes. According to the present invention, an insulin resistance improving agent or a therapeutic agent for type II diabetes comprising a compound represented by general formula (I) (wherein R1, R2, and R3 are the same as or different from each other, and each represents lower alkyl, lower alkenyl, lower alkynyl, aralkyl, araryl, phenyl, or a hydrogen atom) or a salt thereof as an active ingredient can be provided.
    Type: Grant
    Filed: September 19, 2007
    Date of Patent: January 17, 2012
    Assignees: Kyowa Hakko Bio Co., Ltd., Mitsubishi Gas Chemical Company, Inc.
    Inventors: Mika Sumi, Fumiko Ogino, Toshikazu Kamiya, Masahiko Nakano, Kazutoshi Kikkawa
  • Publication number: 20100190815
    Abstract: It is an objective of the present invention to provide a safe and highly effective hypertension-ameliorating agent. The present invention provides a hypertension-ameliorating agent, comprising a compound represented by general formula (I) (wherein R1, R2, and R3 are the same as or different from each other, and each represents lower alkyl, lower alkenyl, lower alkynyl, aralkyl, araryl, phenyl, or a hydrogen atom) or a salt thereof as an active ingredient.
    Type: Application
    Filed: September 7, 2007
    Publication date: July 29, 2010
    Applicants: KYOWA HAKKO BIO CO., LTD., MITSUBISHI GAS CHEMICAL COMPANY, INC.
    Inventors: Fumiko Ogino, Toshikazu Kamiya, Masahiko Nakano, Kazutoshi Kikkawa
  • Publication number: 20100093780
    Abstract: An object of the present invention is to provide a safe and highly effective insulin resistance improving agent or therapeutic agent for type II diabetes. According to the present invention, an insulin resistance improving agent or a therapeutic agent for type II diabetes comprising a compound represented by general formula (I) (wherein R1, R2, and R3 are the same as or different from each other, and each represents lower alkyl, lower alkenyl, lower alkynyl, aralkyl, araryl, phenyl, or a hydrogen atom) or a salt thereof as an active ingredient can be provided.
    Type: Application
    Filed: September 19, 2007
    Publication date: April 15, 2010
    Applicants: KYOWA HAKKO BIO CO., LTD., MITSUBISHI GAS CHEMICAL COMPANY, INC.
    Inventors: Mika Sumi, Fumiko Ogino, Toshikazu Kamiya, Masahiko Nakano, Kazutoshi Kikkawa
  • Patent number: 7485662
    Abstract: An object of the present invention is to provide a therapeutic agent for diabetes mellitus or insulin resistance improving agent, or to provide foods and drinks, food and drink additives, and feeds or feed additives for treating diabetes mellitus or improving insulin diabetes. In order to achieve such an object, the present invention provides a therapeutic agent for diabetes mellitus and insulin resistance improving agent comprising hydroxyproline, a hydroxyproline derivative or a pharmaceutically acceptable salt thereof or foods and drinks, food and drink additives, feeds or feed additives for treatment of diabetes mellitus or improvement of insulin resistance comprising the same.
    Type: Grant
    Filed: March 19, 2004
    Date of Patent: February 3, 2009
    Assignee: Kyowa Hakko Kogyo Co., Ltd.
    Inventors: Toshikazu Kamiya, Akio Shirai, Miho Takada, Fumiko Ogino
  • Publication number: 20060173066
    Abstract: An object of the present invention is to provide a therapeutic agent for diabetes mellitus or insulin resistance improving agent, or to provide foods and drinks, food and drink additives, and feeds or feed additives for treating diabetes mellitus or improving insulin diabetes. In order to achieve such an object, the present invention provides a therapeutic agent for diabetes mellitus and insulin resistance improving agent comprising hydroxyproline, a hydroxyproline derivative or a pharmaceutically acceptable salt thereof or foods and drinks, food and drink additives, feeds or feed additives for treatment of diabetes mellitus or improvement of insulin resistance comprising the same.
    Type: Application
    Filed: March 19, 2004
    Publication date: August 3, 2006
    Applicant: Kyowa Hakko Kogyo Co., Ltd.
    Inventors: Toshikazu Kamiya, Akio Shirai, Miho Takada, Fumiko Ogino
  • Publication number: 20060046992
    Abstract: The present invention provides a compound represented by formula (I): [wherein X—Y-Z represents R5N—C?O (wherein R5 represents a hydrogen atom, substituted or unsubstituted lower alkyl, substituted or unsubstituted aralkyl, substituted or unsubstituted lower alkenyl, or substituted or unsubstituted lower alkynyl), etc; R1 and R2 may be the same or different and each represents a hydrogen atom, substituted or unsubstituted lower alkyl, etc; and R3 and R4 may be the same or different and each represents a hydrogen atom, substituted or unsubstituted lower alkyl, etc], or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: June 25, 2003
    Publication date: March 2, 2006
    Applicant: Kyowa Hakko Kogyo Co., Ltd.
    Inventors: Daisuke Machii, Koji Suzuki, Tsutomu Matsumura, Hitoshi Arai, Miho Iwase, Hiroshi Yano, Satoshi Nakanishi, Fumiko Ogino, Kotaro Takasaki, Hideaki Kusaka